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The post-natal cochlear mammalian epithelium have no capacity to proliferate in tissue, 
however, dissociated supporting cells exhibit the ability to divide and trans-differentiate 
into new hair cells in vitro, with this process found to be correlated with the 
downregulation of the cyclin-dependent kinase inhibitor p27kip1. Here we show that 
knockdown of p27kip1 with short hairpin RNA-expressing vectors results in the 
cell-cycle reentry of post-mitotic supporting cells in the post-natal mouse cochleae ex 
vivo. The p27kip1-knockdown cells incorporated BrdU, and then divided into two 
daughter cells. However, there was also activation of the apoptotic pathway in some 
supporting cells. These results indicate that the use of RNA interference to target p27kip1 
is an effective strategy for inducing cell-cycle reentry in post-mitotic supporting cells in 
the post-natal mammalian cochleae, although additional manipulations of the supporting 
cells are required to achieve hair cell regeneration. 
 




Sensorineural hearing loss (SNHL) is one of the most common disabilities. Auditory 
hair cells in the cochlea are mechanoreceptors that play a crucial role in hearing. In 
mammals, if the hair cells are damaged or lost, the resulting SNHL is permanent. 
Therefore, one of the best approaches for improving hearing in mammals would be to 
find a way to induce hair cell regeneration. 
The cochlear epithelium is composed of hair cells and supporting cells (SCs). In the 
avian auditory epithelium, SCs are able to reenter the cell cycle and proliferate in 
response to hair cell loss, which gives rise to both new hair cells and SCs (Corwin and 
Cotanche, 1988; Ryals and Rubel, 1988). In mice, progenitors of the cochlear 
epithelium stop dividing by embryonic day 14.5 (Ruben, 1967), with differentiation of 
the hair cells and SCs occurring after this terminal mitosis. Both hair cells and SCs 
maintain a post-mitotic state throughout life in adult mammals, and do not exhibit any 
spontaneous capacity to divide under normal conditions or in response to damage in 
vivo (Roberson and Rubel, 1994).  
It has been determined that the cyclin-dependent kinase inhibitor (CKI), p27kip1, 
plays a crucial role in the entry of mammalian SCs into the G0 phase (Chen and Segil, 
1999; Lowenheim et al., 1999). CKIs function by binding to and inhibiting the activity 
of the cyclin-dependent kinases that promote cell cycle progression and fulfill the cell 
cycle checkpoint functions (Sherr and Roberts, 1999). The p27kip1 acts as a negative 
regulator of the G1-S transition in the cell cycle (Harpper, 2001). Studies on 
p27kip1-deficient mice have shown that when deleted, it results in the continued 
proliferation of SCs in postnatal mouse cochlear epithelia (Chen and Segil, 1999; 
Lowenheim et al., 1999). Recently, White et al. have reported that after dissociation, 
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some of the mammalian SCs are able to recover their proliferative abilities (White et al. 
2006). In addition, these dissociated SCs can also trans-differentiate into hair cells in 
vitro. These findings suggest that while these mammalian SCs might have a 
regenerative potential similar to avian auditory epithelia, this potential is suppressed 
within the tissue. This previous study also found that there was a correlation between 
the reduced expression levels of p27kip1 and the ability of the mammalian supporting 
cells to reenter the cell cycle in vitro. Overall, these previous results suggest that 
manipulation of the p27kip1 levels could be used therapeutically to stimulate the 
proliferation of mammalian SCs in tissue.  
Discovery of gene inactivation by RNA interference (RNAi) has led to the 
development of a new targeted therapy for inner ear disease at the molecular level (Fire 
et al., 1998). RNAi is a two-stage intracellular process that converts the double-stranded 
RNA molecule precursors into functional small interfering RNAs. These small 
interfering RNAs are then incorporated into RNA-inducing silencing complexes. 
Subsequently, these duplexes unwind, with one strand used to target sequence-specific 
cleavage of the messenger RNAs that ultimately cause the knockdown of the expression 
of the targeted proteins (Elbashir et al., 2001).  
Although studies on p27kip1-deficient mice have shown that its deletion results in 
continued SC proliferation in postnatal mouse cochlear epithelia (Chen and Segil, 1999; 
Lowenheim et al., 1999), the consequences of acute removal of p27kip1 from 
differentiated SCs have yet to be examined. Therefore, the aim of the current study was 
to examine the efficacy of RNAi in silencing p27kip1 in cochlear explant cultures from 
post-natal mice, and its potential for inducing mitosis in post-mitotic SCs in the 
cochlear epithelia after birth. 
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Results and Discussion 
Co-transfection efficiency 
In this study, the two different plasmids were simultaneously introduced into the 
cochlear explants in order to label cells in which short hairpin RNAs (shRNAs) were 
transfected. To examine the efficiency of co-transfection, we introduced two different 
plasmids, EGFP- and DsRed-expressing vectors, into five cochlear explants via 
electroporation. One day after the electroporation, EGFP+ cells were found in all 
explants, with the majority co-expressing DsRed (Figs. 1a, b). Immunostaining for 
p27kip1 identified SCs within the cochlear epithelia (Fig. 1c). DsRed was expressed in 
32.5 ± 11.0 / 33.0 ± 10.9 EGFP+, p27kip1+ cells (98.5%), and there were 32.5 ± 11.0 / 
33.5 ± 12.4 DsRed+, p27kip1+ cells (97.0%) that expressed EGFP. These results 
demonstrated that electroporation was able to simultaneously introduce two different 
plasmids into the SCs. 
 
Silencing p27kip1 expression in SCs by RNAi 
ShRNA for p27kip1-expressing vectors, sh-p27a, or the control scrambled shRNA vector, 
sh-scr, were co-electroporated with pEGFP-N1 into cochlear explants (n = 5 in each 
condition). Two days after the introduction of a mixture of sh-scr and pEGFPN-1, 48.4 
± 13.7 EGFP-expressing cells were found in the whole single cochlear explant, with all 
the EGFP-expressing cells positive for p27kip1 (Figs. 2g-h’). These results indicate that 
transfection of plasmids into SCs did occur and that there was no silencing of the 
expression of p27kip1. In sh-p27a-transfected explants, 28.4 ± 7.8 / 29.7 ± 7.7 
EGFP-expressing cells (95.4%) exhibited no expression of p27kip1 (Figs. 2i-l), 
indicating that silencing of the expression of p27kip1 occurred in these SCs.  
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To confirm that EGFP+ and p27kip1-cells were SCs after the knockdown of p27kip1, 
we performed immunostaining for myosin VIIa and Sox2 in explants in which sh-p27a 
has been introduced. Cochlear specimens of post-natal day 3 (P3) mice 1 day in vitro 
were used as the immunohistochemistry controls. In controls, immunostaining for 
myosin VIIa and p27kip1 clearly demonstrated the location of the hair cells (Figs. 2a, d), 
and the p27kip1–labeled SC layer (Figs. 2b, e), which was located underneath the hair 
cell layer. Sox2 was strongly expressed in the SCs in the organ of Corti and in the inner 
sulcus region (which corresponds to the interior of the organ of Corti), but in the outer 
sulcus region (which corresponds to the exterior of the organ of Corti), it was either 
faintly seen or not found at all within the SCs (Figs. 2c, f), which is identical to 
previous findings (Oesterle et al., 2008; Hume et al., 2007). In sh-p27a-transfected 
specimens (n = 5), double labeling for myosin VIIa and p27kip1 demonstrated that the 
EGFP+ and p27kip1- cells were located underneath the myosin VIIa+ hair cell layer (Fig. 
2i’), which was coincident with the location of the SCs. Double labeling for Sox2 and 
p27kip1 demonstrated that all EGFP+ and p27kip1- cells that were located in the organ of 
Corti (41 cells in four explants) were positive for Sox2 (Figs. 2k-m). Overall, these 
results demonstrated that the introduction of sh-p27 efficiently silenced p27kip1 
expression in the SCs.  
In addition, to examine the efficacy of transfection in pillar cells and Deiters' cells, 
immunostaining for Prox1 was performed (Kirjavainen et al. 2008). In P3 mouse 
cochleae, the expression of Prox1 was found in pillar cells and Deiters' cells (Fig. 3a). 
In sh-p27a-transfected specimens (n = 7), a few EGFP+ Prox1+ cells were found (Figs. 
3b-d). The mean was 2.1 ± 1.9 cells in the whole single cochlea, which is 4.4 ± 3.5% of 
total EGFP+ cells in the whole single cochlea. Other EGFP-expressing cells were 
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located in the outer sulcus region. In the inner sulcus region, no EGFP-expressing cells 
were found. 
 
S-phase reentry of SCs by silencing p27kip1 
To examine whether p27kip1 silencing had an effect on the reentry of SCs into the cell 
cycle, a 5-bromo-2-deoxyuridine (BrdU)-labeling assay was employed. To confirm that 
the S-phase reentry of the SCs is specific to the knockdown of p27kip1, we used two 
different shRNAs to target p27kip1 in this experiment. Explants after introduction of the 
plasmid mixtures, pEGFP-N1 and, sh-p27a (n = 9), sh-p27b (n = 5) or sh-scr (n = 5) 
were used. Three days after the introduction of a mixture of sh-scr and pEGFPN-1, there 
were no double-positive BrdU+ EGFP+ cells seen in the cochlear epithelia (Figs. 4a-d). 
While we found that a few mesenchymal cells located under the basement membrane of 
the cochlear epithelium were positive for BrdU, all of these were found to be negative 
for EGFP (Figs. 4a’-d’). In an explant transfected with sh-p27a, 13.8 ± 6.8 / 48.2 ± 15.2 
EGFP+ cells (28.6%) were labeled by BrdU with no expression of p27kip1 (Figs. 4e-h’). 
In cochlear explants transfected with sh-p27b, BrdU+, EGFP+ cells were also found in 
the cochlear epithelia (Figs. 4i-l’). BrdU incorporation was identified in 7.6 ± 4.7 / 24.6 
± 15.0 EGFP+ cells (30.9%). These results demonstrated that silencing p27kip1 
expression occurred after transfection of shRNA that was directed against p27kip1 and 
led to the initiation of S-phase reentry of the post-mitotic SCs. However, the knockdown 
of p27kip1 did not induce S-phase reentry in approximately 70% of transfected cells. 
There are two possible explanations for this. One is that insufficient suppression of 
p27kip1 , which was not enough for S-phase reentry, occurred in 70% of transfected cells. 
Another is that other cell-cycle inhibitors compensate the function of p27kip1.  
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Mitosis in SCs induced by RNAi with p27kip1 
We performed time-lapse observations and propidium iodide (PI) staining in order to 
document the characteristic morphology for mitosis in SCs in which the p27kip1 had 
been silenced. Two days after the introduction of a mixture of sh-p27a and pEGFPN-1, 
time-lapse observations of EGFP+ cells demonstrated mitosis in SCs within the explants 
(Figs. 5a, b, S1). We observed 10 EGFP+ cells in the outer sulcus region. In five out of 
the 10 EGFP+ cells that were recorded, the cells became rounded in shape and then 
divided into two daughter cells, which stained for BrdU but did not show any labeling 
for p27kip1 (Figs. 5c, d). In addition, cross sections clearly showed nuclear migration to 
the luminal portion of the SCs (Figs. 5c’, d’). During this process, PI staining of the 
nuclear chromatin demonstrated that there was segregation of the chromosomes in the 
EGFP+ cells (Figs. 5e, f). Thus, these results showed that silencing of the p27kip1 
expression in post-mitotic SCs induced mitosis of the SCs in postnatal cochlear 
epithelia. This provides direct evidence that p27kip1 plays a central role in controlling the 
proliferation of the SCs in neonatal cochleae. White et al. have reported that the 
capacity of SCs for proliferation is diminished depending on ages (White et al. 2006). 
Therefore, further experiments are required to date the efficacy of RNAi for p27kip1 for 
induction of SC proliferation in adult mouse cochleae.  
 
Fate of SCs after p27kip1 silencing 
To examine the effect of silencing p27kip1 expression on the survival of post-mitotic 
SCs, we counted the number of EGFP+ cells in the cochlear epithelia that had been 
introduced a mixture of pEGFPN-1 and sh-p27a or sh-scr (Fig. 6). Quantitative analysis 
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of the EGFP+ cell survival demonstrated no significant differences in the number of 
surviving cells among culture periods in explants transfected with sh-scr, while there 
were significant reduction in the number of transfected cells was found in explants 
transfected with sh-p27a (Fig. 6). The number of EGFP+ cells on day 5 or 7 was 
significantly lower than that on day 1 or 2. These findings indicate that introduction of 
sh-p27a induced the loss of transfected SCs. We also examined the numbers of EGFP+, 
BrdU+ cells, cell-cycle reentering cells, in explants transfected with a mixture of 
sh-p27a and pEGFPN-1. BrdU incorporation was not found in EGFP+cells on day 1, 
while on days 2-7, EGFP+, BrdU+ cells were observed in explants that had been 
introduced sh-p27a. There were significant differences in the number of EGFP+, BrdU+ 
cells between day 2 and day 3, 5, or 7 (Fig. 6). Fig. 6 indicates that the reduction of 
EGFP+ cells between day 2 and 3 mainly caused by the reduction of EGFP+, BrdU+ 
cells, and that the reduction of EGFP+ cells between day 3 and 5 was due to the loss of 
EGFP+, BrdU- cells. Therefore, both reentry of cell cycle by silencing p27kip1 
expression and silencing p27kip1 expression itself may induce degeneration of 
transfected SCs.  
We then investigated the cell death mode that occurred after silencing p27kip1 
expression. Immunohistochemical labeling for cleaved caspase 3 along with PI staining 
was performed in the explants 3 days after introduction of a mixture of sh-p27a and 
pEGFPN-1. The activation of caspase 3 was identified in 9/327 EGFP+ cells in six 
explants (Fig. 7a). PI staining showed the fragmentation of nuclear chromatin in 
EGFP+ and cleaved caspase 3+ cells (Fig. 7b). In addition, we examined the effects of 
the addition of a caspase 3 inhibitor to the culture medium. Addition of the caspase 3 
inhibitor significantly increased the number of EGFP+ cells in explants transfected with 
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sh-p27a (two-way factorial ANOVA, p < 0.0001, Fig. 8). However, the caspase 3 
inhibitor did not completely prevent the loss of EGFP+ cells, as over time, the explants 
treated with the caspase 3 inhibitor exhibited a decrease in their numbers (Fig. 8). All 
these results indicated that silencing the p27kip1 expression in post-mitotic SCs initiated 
apoptosis in at least some, but not all of the cells. These results are consistent with 
previous data reported for apoptosis in mouse hair cells after the deletion of pRb 
(Mantela et al., 2005; Sage et al., 2005; Weber et al., 2008), p19ink4d (Chen et al., 2003) 
or both p19ink4d and p21cip1 (Lane et al., 2007). On the other hand, the results indicate 
that other mechanisms rather than degradation via apoptosis are involved in the loss of 
transfected SCs. Hence, further investigations are necessary to reveal mechanisms for 
the loss of transfected SCs.  
On the other hand, even at 7 days after the introduction of a mixture of sh-p27a and 
pEGFPN-1, EGFP+, BrdU+ cells were still observed in cochlear epithelia that had been 
transfected with sh-p27a. To examine the potential of silencing p27kip1 expression for 
trans-differentiation of SCs into hair cells, specimens that had been transfected with 
sh-p27a were immunohistochemically labeled for myosin VIIa. The results showed that 
there was no myosin VIIa labeling noted in the EGFP+ cells on days 5 and 7 (data not 
shown). These findings indicate that no SCs in which the p27kip1 expression had been 
silenced underwent the trans-differentiation into hair cells. On the other hand, a separate 
study that used dissociated SCs showed the ability of post-mitotic SCs to 
trans-differentiate into hair cells in combination with the downregulation of p27kip1 in 
vitro (White et al., 2006). Therefore, it appears that further manipulations are required in 
order to achieve hair cell regeneration in tissue. 
When there is manipulation of Notch signaling by gene transfer (Kawamoto et al., 
 11 
2003) or by pharmacological inhibitors (Yamamamoto et al., 2006), the formation of 
ectopic hair cells in the outer sulcus region was observed, suggesting that SCs in this 
region are able to retain their ability to trans-differentiate into hair cells. In the avian 
auditory epithelium, the loss of hair cells is a key trigger that leads to the conversion of 
SCs to hair cells, a process for which Notch signaling is also involved (Stone and Rubel., 
1999; Cafaro et al., 2007). In the mammalian cochlear epithelium, transient activation of 
Notch signaling has been observed in SCs following hair cell loss (Hori et al., 2007; 
Batts et al., 2009), suggesting that additional manipulation of Notch signaling in SCs 
could possibly contribute to the regeneration of hair cells once there is induction of SC 
proliferation by RNAi with p27kip1. 
Sage et al. (2005) demonstrated that there was proliferation of SCs in the cochlear 
epithelia of pRb-/- mice, indicating that pRb can be a target to induce cell-cycle reentry 
of post-mitotic SCs in tissue. However, pRb expression is undetectable in SCs in 
post-natal cochlear epithelia in normal mice (Mantela et al., 2005). Therefore, pRb 
expression does not appear to be an attractive candidate for induction of mitosis in 
post-natal SCs. In contrast, post-natally in normal mice, the p27kip1 expression is strong 
and stable in the SCs (Chen and Segil, 1999; Lowenheim et al., 1999; Endo et al., 2002; 
White et al., 2006). Based on these reports, we considered p27kip1 to be an appropriate 
target for induction of SC proliferation in the mammalian cochlear epithelium. 
In conclusion, this is the first report showing induction of mitosis in post-mitotic 
mammalian SCs in tissue by RNAi targeting of p27kip1. The present findings indicate 
that p27kip1 expression is sufficient for maintaining the post-mitotic state of the SCs in 
tissue, and that RNAi is an efficient strategy for knockdown of the expression of p27kip1 
in the SCs of post-natal mammalian cochlear epithelia. On the other hand, our data have 
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also identified obstacles that need to be overcome in order to achieve hair cell 
regeneration via the stimulation of SC proliferation. The most critical of these factors is 
the activation of the apoptotic pathways in SCs after silencing the expression of p27kip1. 
Induction of trans-differentiation of the SCs into hair cells is also indicated obstacles to 
be overcome. Therefore, further manipulations are required for preventing apoptosis and 






ICR mice (Japan SLC Inc., Hamamatsu, Japan) were maintained at the Institute of 
Laboratory Animals, Graduate School of Medicine, Kyoto University, Japan. 
Experimental protocols were approved by the Animal Research Committee of Kyoto 
University Graduate School of Medicine (MedKyo07062), and complied with the US 




P3 ICR mice (were deeply anesthetized with carbon dioxide and decapitated. The 
temporal bones were dissected out and the cochleae removed from the surrounding 
tissue in 0.01 M phosphate-buffered saline (PBS), pH 7.4, which was supplemented 
with 0.2% glucose. The lateral walls were removed from the cochleae and the cochlear 
epithelia were dissected from the cochlear modiolus and placed intact on sterile 
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membranes in culture inserts (12 mm Millicell CM, Millipore, Billerica, MA). These 
explants were maintained in 24-well culture plates (Iwaki, Tokyo, Japan) in minimum 
essential medium (MEM; Invitrogen, Carlsbad, CA) supplemented with 3 mg/ml 
glucose and 0.3 mg/ml penicillin G potassium salt (Nacalai Tesque, Kyoto, Japan), at 
37°C in a humidified atmosphere of 95% air and 5% CO2 for 24 h. The cultured 
explants were then used for the electroporation experiments. 
 
Plasmids  
ShRNAs, are RNA sequences that make tight hairpin turns and can silence gene 
expression via RNAi (Paddison et al., 2002). These sequences are expressed in vectors 
and can be used to target the p27 kip1 coding sequence (sh-p27) or to act as a control 
scrambled sequence (sh-scr). The two different sh-p27s prepared for this experiment 
were sh-p27a and sh-p27b. The sequences were 5′ -AGACAATCAGGCTGGGTTA-3′ 
for sh-p27a, 5′-GAAGCGACCTGCTGCAGAA-3′ for sh-p27b and 
5′-TACGCGCATAAGATTAGGG-3′ for the sh-scr control sequence. These 
complementary sequences were inserted into the mU6 pro vector. The efficacy of 
sh-p27s in silencing the p27kip1 expression in neuronal cells has been previously 
demonstrated (Kawauchi et al., 2006). pEGFP-N1 and pDsRed-Express-N1 vectors 
were purchased from Clontech (Palo Alto, CA). Each plasmid DNA was propagated in 
DH5α Escherichia coli and purified using an Endo Free Plasmid Maxi Kit (Qiagen, 
Valencia, CA). The yield and purity of the plasmid DNA was evaluated using an 




For the electroporation experiments, we prepared four kinds of plasmid mixtures that 
included, pDsRed-Express-N1 and pEGFP-N1, sh-p27a and pEGFP-N1, sh-p27b and 
pEGFP-N1 and sh-scr and pEGFP-N1. All vectors were diluted in electroporation buffer 
(125 mM NaCl, 5 mM KCl, 1.5 mM MgCl2, 10 mM glucose, 20 mM Hepes, pH 7.4) to 
a concentration of 1.5 mg/ml. A CUY21 electroporator (Nepa Gene, Chiba, Japan) was 
used to transfer the plasmid mixtures into the auditory epithelial cells from the explant 
cultures. Culture inserts were placed on the lower platinum electrode, with 10 µl of the 
plasmid DNA solution then applied between them. Eight rectangular pulses (14 V, 50 
ms duration at 100-ms intervals) were passed from the upper to the lower electrodes, 
followed by an additional eight pulses that were applied from the lower to the upper 
electrodes. Afterwards, explant cultures were maintained in culture medium 
supplemented with 3 µg/ml BrdU (Sigma-Aldrich, St. Louis, MO) for 1-7 days. The 
culture medium was changed daily. Ten cochlear epithelia were used for a single culture, 
with ten independent cultures performed.  
 
Immunohistochemistry 
Explants were fixed in 4% paraformaldehyde (PFA) in PBS for 15 min at room 
temperature, washed with 0.2% Triton-X 100 in PBS (Triton-PBS) and stained as whole 
mounts. After blocking with 10% normal goat serum in Triton-PBS at 4˚C for 60 min, 
the explants were incubated overnight with the following primary antibodies: 
anti-mouse p27kip1 rabbit polyclonal antibody (1:500; Lab Vision, Fremont, CA), 
anti-myosin VIIa rabbit polyclonal antibody (1:500; Proteus Bioscience, Ramona, CA), 
anti-Sox2 goat polyclonal antibody (1:500, Santa Cruz Biotechnology, Inc., Santa Cruz, 
CA), anti-Prox1 rabbit polyclonal antibody (1:1000; Chemicon, Temecula CA), 
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anti-BrdU mouse monoclonal antibody (1:100; Becton Dickinson, Franklin Lakes, NJ), 
and anti-cleaved caspase-3 mouse monoclonal antibody (1:100; #9661S, Cell Signaling 
Technology, Danvers, MA). Alexa Fluor 594-conjugated anti-rabbit antibody, Alexa 
Fluor 633-conjugated anti-mouse, or anti-rabbit antibody (1:500; Invitrogen) was used 
as the secondary antibody and Vectashield (Vector Laboratories, Burlingame, CA) was 
used for mounting the samples. For BrdU staining, the specimens were pre-treated in 
2N HCl for 20 min at 37˚C, and neutralized with 0.01M PBS (pH 8.5) for 1 0 min at 
room temperature. To label for both myosin VIIa and p27Kip1 simultaneously, a ZenonTM 
Alexa Fluor 647 Rabbit IgG Labeling Kit (Invitrogen) was used. PI (Invitrogen) was 
used to stain nuclear chromatin. Images were acquired using a confocal laser scanning 
system (TCS SP2, Leica Microsystems, Wetzlar, Germany). 
 
Co-transfection efficiency 
To examine the efficiency of co-transfecting two different plasmids, we used five 
explants that were transfected with a mixture of pEGFPN-1 and pDsRed-Express-N1 
vectors. To identify the location of the SCs in the cochlear epithelia, the explants were 
labeled immunohistochemically for p27kip1 1 day after the electroporation. We then 
quantified the number of p27kip1+ cells that were also EGFP+ and/or DsRed+.  
 
Silencing p27kip1 expression in SCs by RNAi 
To examine the efficiency of silencing p27kip1 in sh-p27-transfected SCs, explants were 
transfected with a mixture of sh-scr and pEGFPN-1, sh-p27a and pEGFPN-1 or sh-p27b 
and pEGFPN-1 2 days prior to being immunolabeled for p27kip1 (n = 5 in each 
condition). We then quantified the number of p27kip1-EGFP+ and EGFP+ cells in the 
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cochlear epithelia. To examine the location of EGFP+ cells in the cochlear epithelium, 
we counted the number of EGFP+ cells in the outer sulcus region, in the organ of Corti 
and in the inner sulcus region in sh-p27a-transfected specimens.  
To confirm that EGFP+ and p27kip1-cells were SCs after the knockdown of p27kip1, 
immunohistochemistry for p27kip1 and myosin VIIa or Sox2 was performed in explants  
2 days after sh-p27a introduction (n = 5 for myosin VIIa, n = 4 for Sox2). To examine 
the efficacy of transfection in pillar cells and Deiters' cells, immunostaining for Prox1 
was performed in explants 2 days after sh-p27a introduction (n = 7). In order to 
demonstrate normal distributions of these molecules, we used frozen sections or whole 
mounts of P3 ICR mouse cochleae after 1 day in vitro ( n = 10) for the 
immunohistochemistry controls. At the end of the staining procedures, we used 
FITC-phalloidin (Invitrogen) to counterstain the specimens. 
 
S-phase reentry of SCs by silencing p27kip1 
To examine the effect of silencing p27kip1 expression on the S-phase reentry of SCs, we 
used cochlear explants that were introduced a mixture of sh-p27a (n = 9), sh-p27b (n = 
5) or sh-scr (n = 5) and pEGFPN-1 2 days prior to labeling the explants for p27kip1 and 
BrdU. We then counted the number of BrdU+ EGFP+ cells and EGFP+ cells for each 
group. 
 
Mitosis in SCs induced by RNAi with p27kip1 
To examine the effect of p27kip1 silencing on SC division, we used cochlear explants that 
were introduced a mixture of sh-p27a and pEGFPN-1 (n = 10) 2 days prior to making 
time-lapse recordings of the explants using the BZ-9000 system (Keyence, Osaka, 
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Japan). In the different explants, still images were captured for 10 EGFP-expressing 
cells. Immediately after the time-lapse observations were recorded, the specimens were 
fixed with 4% PFA for 15 min at room temperature, and then stained 
immunohistochemically for p27kip1 and BrdU or with PI.  
 
Fate of SCs after p27kip1silencing 
To determine the effect of p27kip1 silencing on the survival and differentiation of 
post-mitotic SCs, mixtures of sh-p27 and pEGFPN-1 or sh-scr and pEGFPN-1 were 
introduced into cochlear explants at 1, 2, 3, 5 and 7 days (n = 5-10) prior to the counting 
of the number of EGFP+ or EGFP+, BrdU+ cells.  
Six explants into which a mixture of sh-p27a and pEGFPN-1 had been 
introduced 3 days earlier were labeled immunohistochemically for cleaved caspase 3 
and stained with PI in order to investigate the activation of the apoptotic pathways. In 
addition, we also clarified the caspase 3-dependency of SC death following the 
silencing of p27kip1 expression by examining explants that were cultured in medium 
supplemented with 100 µM Caspase-3 inhibitor III (Calbiochem, San Diego, CA) after 
a mixture of sh-p27a and pEGFPN-1 had been introduced. The numbers of EGFP+ cells 
after 2-7 days of culturing were counted (n = 5 for each time point). 
To examine the trans-differentiation of SCs into hair cells after silencing the 
p27kip1 expression, myosin VIIa was labeled immunohistochemically in explants into 
which a mixture of sh-p27a and pEGFPN-1 had been introduced 5 or 7 days earlier (n = 




The effects of silencing p27kip1 expression and inhibiting caspase 3 on the survival of 
EGFP+ cells in auditory epithelia were examined using a two-way factorial analysis of 
variance (ANOVA). When an interaction was determined to be significant, pair-wise 
comparisons were analyzed using the Tukey-Kramer test for multiple comparisons. A 
one-way factorial ANOVA with the Tukey-Kramer test was used for analysis of 
differences for the number of EGFP+, BrdU+ cells among cultured periods in cochlear 
explants that were introduced a mixture of pEGFPN-1 and sh-p27a. The data was 
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Fig 1. Electroporation-mediated co-transfection of two different plasmids into cochlear 
supporting cells.  
Co-expression of EGFP (a) and DsRed (b) are found in supporting cells, which is 
identified by p27kip1 immunostaining (c) 1 day after electroporation (arrows). IS, inner 
sulcus; OC, organ of Corti; OS, outer sulcus. Scale bar = 30 µm. 
 
Fig 2. Knockdown of p27kip1 expression by RNAi occurred in supporting cells. 
Expression of myosin VIIa , p27kip1 and Sox2 in sections (a-c) or in whole-mounts (d-f) 
are shown. Green fluorescence in a-c shows phalloidin staining. Asterisks in b,c 
indicate the location of hair cells. In cochlear epithelia transfected with sh-scr (g,h), 
EGFP+ cells (arrowheads) express p27kip1. Cross-section images along with white 
dotted lines in g-j show in g’-j’. In cochlear epithelia transfected with sh-p27a (i-m), 
EGFP+ cells (arrows) are negative for p27kip1. Double-labeling for myosin VIIa and 
p27kip1 demonstrates the location of a transfected cell (arrow in i’) corresponding to the 
supporting cell. Double-labeling for Sox2 and p27kip1 (k-m) demonstrates the 
expression of Sox2 in EGFP+, p27kip1- cells (arrows), indicating that p27kip1 silencing 
occurs in supporting cells. A part of EGFP+, p27kip1- cells lacks Sox2 expression 
(arrowhead in k-m). Myo7a, Myosin VIIa; IS, inner sulcus; OC, organ of Corti; OS, 
outer sulcus. Scale bars = 30 µm.  
 
Fig. 3. Transfection in Prox1-positive supporting cells. 
In normal P3 cochlear epithelia, Prox1 expression (red) is seen in pillar cells and 
 24 
Deiters’ cells (a). Green fluorescence in a shows phalloidin staining (Pha), and blue 
shows nuclear staining with DAPI. Asterisks in a indicate the location of hair cells. 
Some EGFP+ cells exhibit Prox1 expression (arrows in b-d), while other EGFP+ cells 
in the outer sulcus are negative for Prox1 (arrowheads in b-d). IS, inner sulcus; OC, 
organ of Corti; OS, outer sulcus. Scale bars = 20 µm. 
 
Fig. 4. Supporting cells silenced p27kip1 by RNAi reenter S-phase.  
In cochlear epithelia following introduction of sh-scr, EGFP+ cells exhibit expression of 
p27kip1 and are negative for BrdU (arrowheads in a-d). In cross-section images (a’-d’) 
along with white dotted lines in a-d, a cell located underneath the cochlear epithelium 
shows BrdU incorporation (asterisk). In cochlear epithelia following introduction of 
sh-p27a (e-h) or sh-p27b (i-l), some of EGFP+, p27kip1- cells exhibit BrdU 
incorporation (arrows). Other EGFP-positive cells (arrowheads in e-h) show silencing 
of p27kip1, but no incorporation of BrdU. IS, inner sulcus; OC, organ of Corti; OS, outer 
sulcus. Scale bar = 30 µm.  
 
Fig. 5. Mitosis in supporting cells silenced p27kip1 by RNAi.  
Time-lapse observation demonstrates division of sh-p27a-transfected supporting cells 
(a,b). A dividing cell expressing EGFP is positive for BrdU, but not for p27kip1 (arrows 
in c,d). Cross-section images along with white dotted lines in c,d show migration of a 
BrdU+ nucleus to the luminal surface of the supporting cell (arrowheads in c’,d’). An 
EGFP+ supporting cell in the outer sulcus region exhibits the segregation of 
chromosomes (arrowheads in e,f). PI, Propidium iodide, IS, inner sulcus; OC, organ of 
Corti; OS, outer sulcus. Scale bar = 30 µm.  
 25 
 
Fig. 6. Effects of silencing p27kip1and cell-cycle reentry on transfected supporting cell 
survival. 
The surviving EGFP+ cell numbers in sh-scr-transfected explants (black column) show 
no significant alteration among culture periods, while those in sh-p27a-transfected 
explants (white column) significantly decreased over time. Significant decreases in 
numbers EGFP+, BrdU+ cells that have reentered cell-cycle, in sh-p27a-transfected 
explants (grey column)are observed on days 3-7 in comparison with day 2. Asterisks 
indicate statistical significance with the Tukey-Kramer test. Bars represent standard 
deviation. 
 
Fig. 7. Activation of caspase 3 in supporting cells that had been silenced p27kip1 in the 
outer sulcus region.  
The expression of cleaved caspase 3 is found in sh-p27a-transfected supporting cells (a). 
PI staining exhibits the fragmentation of nuclear chromatins in sh-p27a-transfected 
supporting cells expressing EGFP (b). Scale bar = 10 µm. 
 
Fig. 8. Effect of a caspase 3 inhibitor on the number of surviving supporting cells 
following p27kip1silencing.  
Closed squares show the numbers of EGFP+ cells in sh-p27a-transfected explants 
cultured without a caspase 3 inhibitor, and open circles show those with a caspase 3 
inhibitor. An overall effect of application of a caspase 3 inhibitor is significant at p < 
0.001 with two-way factorial ANOVA, No significant differences in the numbers of 
EGFP+ cells were identified with pair-wise comparisons with Tukey-Kramer test. Bars 
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represent standard deviation. 
 
SUPPREMENTARY MATERIAL 
S1. Time-lapse observation showing division of supporting cells that had been 
transfected with sh-p27a and pEGFPN-1 two days earlier. Moving images were 
recorded every 30-second for 15 min. Scale bar = 30 µm. 








